|
The cause of scleroderma is not known. It is hoped that research into the cause of scleroderma might lead to new advances in treatment and intervention. Scleroderma Australia aims to encourage and stimulate new ideas in the search for the cause and treatment of scleroderma through its research program which will be funded by member states, corporate and individual sponsors. |
-
Research Program 2011
( 2 Articles )
-
Medical and Scientific Advisory Board (MSAB)
( 0 Articles )
Medical and Scientific Advisory Board members come from different states in Australia and reflect a range of therapeutic areas affected in scleroderma. Currently, MSAB members are:
- Eli Gabbay, Respiratory, WA
- Fiona Kermeen, Respiratory, Qld
- Eugene Kotlyar, Cardiology, NSW
- Susanna Proudman, Rheumatology, SA
- Janet Roddy, Rheumatology. WA
- Glenn Reeves, Immunology, NSW
- Les Schreiber, Rheumatology, NSW
- Wendy Stevens, Rheumatology, Vic
-
Recently Published Articles
( 2 Articles )
-
Research Program 2010
( 4 Articles )
The cause of scleroderma is not known. It is hoped that research into the cause of scleroderma might lead to new advances in treatment and intervention. Scleroderma Australia aims to encourage and stimulate new ideas in the search for the cause and treatment of scleroderma through its research program which will be funded by member states, corporate and individual sponsors.
-
Donations
( 1 Article )
-
Research Program 2009
( 2 Articles )
|
Research
